Concepedia
Statistics
Publications
20
Citations
1.6K
H-Index
16
Active since
1998
Affiliations
Tokyo Metropolitan Komagome Hospital(Current)
Keio University
Kyowa Hakko Kirin (Singapore)
The University of Tokyo
Japan Science and Technology Agency
Mariko Muta is an author at Tokyo Metropolitan Komagome Hospital specializing in medicine, oncology, and molecular oncology.
Publications per year
1998–2010
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Takayuki Ueno, Masakazu Toi, Hisashi Saji et al. · PubMed · 2000 · 711 citations
Life Sciences, Cancer Biology, Oncology +17
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor‐1 relationship in breast cancer
Masakazu Toi, Hiroko Bando, T Ogawa et al. · International Journal of Cancer · 2001 · 130 citations
Medicine, Cancer Biology, Oncology +16
A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients
Eiji Suzuki, Rinpei Niwa, Shigehira Saji et al. · Clinical Cancer Research · 2007 · 107 citations · Full text
Medicine, Immunology, Oncology +17
Expression of Macrophage Migration Inhibitory Factor in Human Breast Cancer: Association with Nodal Spread
Hiroko Bando, Gaku Matsumoto, Masaki Bando et al. · Japanese Journal of Cancer Research · 2002 · 105 citations · Full text
Medicine, Immunology, Oncology +14
Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Gaku Matsumoto, Jun Ichi Namekawa, Mariko Muta et al. · PubMed · 2005 · 100 citations
Medicine, Oncology, Pharmacology +12
1–5 of 20